Cases & Deals

Maverick Capital invests in Caribou Biosciences

Clients Maverick Capital Ventures LLC

Jones Day represented Maverick Capital Ventures LLC in connection with its purchase of Series B Convertible Preferred Stock in a private placement by Caribou Biosciences, Inc., a developer of CRISPR-Cas technologies for genome engineering. Anterra Capital, Heritage Group, Pontifax AgTech, F-Prime Capital Partners, Novartis, Mission Bay Capital, and 5 Prime Ventures acted as co-investors in the $30 million investment round.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.